中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability

文献类型：期刊论文

作者Pan, Qiang4,5; Zhong, Shanshan6; Wang, Hanling4,5; Wang, Xuege4,5; Li, Ni4,5; Li, Yaqi7,8; Zhang, Guoying4,5; Yuan, Huairui4,5; Lian, Yannan4,5; Chen, Qilong4,5
刊名MOLECULAR CELL
出版日期2021-07-01
卷号81期号:13页码:2736-+
ISSN号1097-2765
DOI10.1016/j.molcel.2021.04.009
通讯作者Peng, Junjie(pengjj67@hotmail.com) ; Xiao, Yichuan(ycxiao@sibs.ac.cn) ; Qin, Jun(qinjun@sibs.ac.cn)
英文摘要Cholesterol metabolism is tightly associated with colorectal cancer (CRC). Nevertheless, the clinical benefit of statins, the inhibitor of cholesterol biogenesis mevalonate (MVA) pathway, is inconclusive, possibly because of a lack of patient stratification criteria. Here, we describe that YAP-mediated zinc finger MYND-type containing 8 (ZMYND8) expression sensitizes intestinal tumors to the inhibition of the MVA pathway. We show that the oncogenic activity of YAP relies largely on ZMYND8 to enhance intracellular de novo cholesterol biogenesis. Disruption of the ZMYND8-dependent MVA pathway greatly restricts the self-renewal capacity of Lgr5(+) intestinal stem cells (ISCs) and intestinal tumorigenesis. Mechanistically, ZMYND8 and SREBP2 drive the enhancer-promoter interaction to facilitate the recruitment of Mediator complex, thus up regulating MVA pathway genes. Together, our results establish that the epigenetic reader ZMYND8 endows YAP-high intestinal cancer with metabolic vulnerability.
WOS关键词SET ENRICHMENT ANALYSIS ; STEM-CELLS ; WEB SERVER ; TRANSCRIPTION ; SREBP ; PROTEIN ; EXPRESSION ; INTERPLAY ; ZMYND8 ; TAZ
资助项目National Key Research and Development Program of China[2018YFA0902700] ; National Natural Science Foundation of China Projects[81825018] ; National Natural Science Foundation of China Projects[81773121] ; National Natural Science Foundation of China Projects[81802818] ; Strategic Priority Research Program of the Chinese Academy of Sciences[XDB19000000] ; Chinese Academy of Sciences[QYZDB-SSW-SMC052] ; Program of Shanghai Academic/Technology Research Leader[19XD1424300] ; Initiative Postdocs Supporting Program of the Ministry of Human Resources and Social Security (MOHRSS) ; National Postdoc Management Committee[bx201800247]
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
出版者CELL PRESS
WOS记录号WOS:000672572800008
源URL[http://119.78.100.183/handle/2S10ELR8/298271]  
专题新药研究国家重点实验室
通讯作者Peng, Junjie; Xiao, Yichuan; Qin, Jun
作者单位1.Army Med Univ, Daping Hosp, Inst Surg Res, Dept Urol, Chongqing 400042, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
3.Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Dept Obstet Gynecol & Pediat, Dept Obstet Gynecol & Pediat,Minist Educ, 20 Renmin South Rd, Chengdu 610041, Peoples R China
4.Shanghai Jiao Tong Univ, Shanghai Inst Nutr & Hlth, CAS Ctr Excellence Mol Cell Sci, CAS Key Lab Tissue Microenvironm & Tumor,Sch Med, 320 Yueyang Rd, Shanghai 200031, Peoples R China
5.Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China
6.Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, 320 Yueyang Rd, Shanghai 200031, Peoples R China
7.Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai 200032, Peoples R China
8.Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
推荐引用方式
GB/T 7714		 Pan, Qiang,Zhong, Shanshan,Wang, Hanling,et al. The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability[J]. MOLECULAR CELL,2021,81(13):2736-+.
APA Pan, Qiang.,Zhong, Shanshan.,Wang, Hanling.,Wang, Xuege.,Li, Ni.,...&Qin, Jun.(2021).The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.MOLECULAR CELL,81(13),2736-+.
MLA Pan, Qiang,et al."The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability".MOLECULAR CELL 81.13(2021):2736-+.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。